Global Health Limited (NSE:MEDANTA)
1,226.90
+27.90 (2.33%)
Nov 21, 2025, 3:30 PM IST
Global Health Revenue
Global Health had revenue of 10.99B INR in the quarter ending September 30, 2025, with 14.91% growth. This brings the company's revenue in the last twelve months to 40.05B, up 15.65% year-over-year. In the fiscal year ending March 31, 2025, Global Health had annual revenue of 36.92B with 12.74% growth.
Revenue (ttm)
40.05B
Revenue Growth
+15.65%
P/S Ratio
8.23
Revenue / Employee
3.90M
Employees
10,260
Market Cap
329.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 36.92B | 4.17B | 12.74% |
| Mar 31, 2024 | 32.75B | 5.65B | 20.86% |
| Mar 31, 2023 | 27.10B | 5.37B | 24.74% |
| Mar 31, 2022 | 21.72B | 7.21B | 49.63% |
| Mar 31, 2021 | 14.52B | -662.81M | -4.37% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Aurobindo Pharma | 325.14B |
| Cipla | 279.66B |
| Zydus Lifesciences | 244.94B |
| Apollo Hospitals Enterprise | 232.65B |
| Biocon | 164.76B |
| Alkem Laboratories | 138.90B |
| Mankind Pharma | 135.46B |
Global Health News
- 10 days ago - Global Health Ltd (BOM:543654) Q2 2026 Earnings Call Highlights: Strong Financial Growth Amid ... - GuruFocus
- 11 days ago - Q2 2026 Global Health Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Global Health share jumps over 4% on strong Q1 earnings; profit rises nearly 50% YoY - Business Upturn
- 4 months ago - Medanta opens new 110-bed hospital in Ranchi, expands capacity - Business Upturn
- 8 months ago - Global Health shares rise over 2% as Medanta evaluates land offer for Assam hospital - Business Upturn
- 8 months ago - Medanta receives offer from Assam govt to set up super speciality hospital in Guwahati - Business Upturn
- 10 months ago - Global Health shares surge over 4% as EBITDA jumps 11% YoY in Q3 - Business Upturn
- 1 year ago - Jefferies maintains Hold call on Medanta, target of Rs 1,170 - Business Upturn